Atomo Diagnostics (AT1) Short Interest
Atomo Diagnostics (ASX:AT1) had 0.26% of shares reported as short positions as of 7 Aug 2023, representing 1,552,633 shares. Atomo Diagnostics operates in the Health Care Equipment & Services industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Atomo Diagnostics
Atomo Diagnostics specializes in the design and production of rapid diagnostic test devices, focusing on user-centered design to improve usability and accuracy. The company is recognized for its innovative platforms that simplify testing processes and reduce user errors, positioning it as a leader in the global rapid diagnostics market.
Short position
Atomo Diagnostics (ASX:AT1) has 0.26% of its shares on issue reported as short positions as of 7 Aug 2023, or about 1,552,633 shares. Over the past 30 days that figure has risen 0.24 percentage points, and over 90 days it has risen 0.24 percentage points. Its highest recorded short interest was 0.79% in October 2020. AT1 is classified in the Health Care Equipment & Services industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4AT1 intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Atomo Diagnostics
Latest AT1 news
All news- Final Director's Interest Notice
asx
- Managing Director & CEO Transition
asx
- Atomo Diagnostics Limited (ASX:AT1) Share Price Remains Unchanged as Stock Trades Within Daily Range - Kalkine
googlenews
- Quarterly Activities/Appendix 4C Cash Flow Report
asx
- Atomo Diagnostics (ASX:AT1) Edges Up 6.25% as Point-of-Care Testing Strategy Progresses - Kalkine
googlenews
About
website
address
More Health Care Equipment & Services Stocks
Other shorted stocks in this sector
Be the first to discuss AT1
Start a research thread or post the first pulse update